Operating Lease, Right-of-Use Asset in USD of GT Biopharma, Inc. from Q4 2018 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
GT Biopharma, Inc. quarterly Operating Lease, Right-of-Use Asset history and change rate from Q4 2018 to Q1 2024.
  • GT Biopharma, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 31 Mar 2024 was $27K, a 80.7% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

GT Biopharma, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed
Q1 2024 $27K -$113K -80.7% 31 Mar 2024 10-Q 15 May 2024
Q4 2023 $53K -$112K -67.9% 31 Dec 2023 10-K 21 Feb 2025
Q3 2023 $87K -$103K -54.2% 30 Sep 2023 10-Q 01 Nov 2023
Q2 2023 $114K -$100K -46.7% 30 Jun 2023 10-Q 07 Aug 2023
Q1 2023 $140K -$97K -40.9% 31 Mar 2023 10-Q 15 May 2023
Q4 2022 $165K -$95.2K -36.6% 31 Dec 2022 10-K 26 Mar 2024
Q3 2022 $190K 30 Sep 2022 10-Q 31 Oct 2022
Q2 2022 $214K 30 Jun 2022 10-Q 15 Aug 2022
Q1 2022 $237K 31 Mar 2022 10-Q 16 May 2022
Q4 2021 $260K +$260K 08 Feb 2022 10-K 30 Mar 2023
Q4 2020 $0 -$110K -100% 31 Dec 2020 10-K 16 Apr 2021
Q3 2020 $72K -$61K -45.9% 30 Sep 2020 10-Q 13 Nov 2020
Q2 2020 $80K -$67K -45.6% 30 Jun 2020 10-Q/A 18 Aug 2020
Q1 2020 $95K -$58K -37.9% 31 Mar 2020 10-Q 15 May 2020
Q4 2019 $110K +$110K 31 Dec 2019 10-K 16 Apr 2021
Q3 2019 $133K 30 Sep 2019 10-Q 14 Nov 2019
Q2 2019 $147K 30 Jun 2019 10-Q 14 Aug 2019
Q1 2019 $153K 31 Mar 2019 10-Q 15 May 2019
Q4 2018 $0 31 Dec 2018 10-K 27 Mar 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.